Madison Williams Starts Dendreon (DNDN) at Sell
Tweet Send to a FriendGet Alerts DNDN Hot Sheet
Price: $4.03 -1.23%
Rating Summary:
5 Buy, 15 Hold, 12 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 21
Rating Summary:
5 Buy, 15 Hold, 12 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 21
Trade DNDN Now!
Madison Williams initiates coverage on Dendreon (NASDAQ: DNDN) with a Sell rating and $27 price target.
For more ratings news on Dendreon click here and for the rating history of Dendreon click here.
Shares of Dendreon closed at $36.65 yesterday, with a 52 week range of $25.05-$57.67.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For more ratings news on Dendreon click here and for the rating history of Dendreon click here.
Shares of Dendreon closed at $36.65 yesterday, with a 52 week range of $25.05-$57.67.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
- UPDATE: BofA/Merrill Lynch Upgrades Adobe (ADBE) to Buy
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
Create E-mail Alert Related Categories
New CoverageComments
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
DNDN initiated with SELL
David Eckes MD on Dec 17, 2010 11:47 AMMark as Spam | Reply to this comment
Shouldn't "full disclosure" require that any company doing a new stock analyst rating accompany that rating with the following information: "my firm has X % of this stock held in long positions and Y % in short positions at the time of this public stock stock announcement?" The credability of this firm is now analyzed as a SELL IMO. The Provenge story and Dendreon has been public/business news for a decade, but these experts are just getting around to analysis and public press releases. At least I am giving you a reason for my SELL rating on the Madison Williams firm; i.e. they lack full disclosure of their stock holding position.